Effects of a Short-term Aerobic Interval Exercise Program on Cardiac Fat and Function in Women With Obesity: A Pilot Study

Obesity Clinical Trial

Official title:

Effects of a Short-term Aerobic Interval Exercise Program on Cardiac Fat and Function in Women With Obesity: A Pilot Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04802005
• Other study ID #: 1063
• Status: Withdrawn
• Phase: N/A
• Start date: March 16, 2021
• Est. completion date: April 16, 2021

Study information

• Verified date: September 2021
• Source: Southern Illinois University Edwardsville
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall goal of this project is to the study the effects of an aerobic interval training program on cardiac fat, and its relationship to cardiac function using cardiac Magnetic Resonance Imaging.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: April 16, 2021
• Est. primary completion date: April 16, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• females, age 18-40 years old, body mass index (BMI) = 30 kg/m2 and < 39.9 kg/m2, without known metabolic and/or cardiovascular disease

Exclusion Criteria:

• known CV, metabolic or pulmonary diseases or conditions, muscular-skeletal injuries (i.e. spine, knees, hips or shoulders, taking medications that affect endocrine or cardiovascular function, hypertension, being engaged in moderate intensity exercise more than two times per week or moderate-high intensity training of any type and frequency, being pregnant, cigarette smoking, having non-removable pieces or devices incompatible with DXA and CMR assessment

Related Conditions & MeSH terms

• Obesity

Intervention

Other:
• Aerobic Interval Training
The aerobic interval training group

Locations

Country	Name	City	State
United States	Southern Illinois University Edwardsville	Edwardsville	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Southern Illinois University Edwardsville

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in Cardiac Adipose Tissue (CAT)	CAT will be measured using cardiac Magnetic Resonance	2 assessment points: at baseline and week 5
Primary	Changes in Cardiac Function	Cardiac Function will be measured using cardiac Magnetic Resonance	2 assessment points: at baseline and week 5
Secondary	Changes in Body Composition	Body composition will be measured using dual-energy x-ray absorptiometry	2 assessment points: at baseline and week 5
Secondary	Changes in Cardiorespiratory Function	Cardiorespiratory Function will be measured on a treadmill with a metabolic cart	2 assessment points: at baseline and week 5
Secondary	Changes in Muscular Strength	Muscular Strength will be assessed through 1 repetition maximum (1RM).	2 assessment points: at baseline and week 5
Secondary	Changes in Blood Pressure	Blood pressure will be measured using pulse wave analysis	2 assessment points: at baseline and week 5